Cargando…
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
The protein tyrosine phosphatase SHP2 activates oncogenic pathways downstream of most receptor tyrosine kinases (RTK) and has been implicated in various cancer types, including the highly aggressive subtype of triple-negative breast cancer (TNBC). Although allosteric inhibitors of SHP2 have been dev...
Autores principales: | Amante, Romain J., Jehanno, Charly, De Silva, Duvini, Coissieux, Marie-May, Ackerknecht, Markus, Romanet, Vincent, Sethi, Atul, Hamelin, Baptiste, Preca, Bogdan-Tiberius, Piscuoglio, Salvatore, Ng, Charlotte K. Y., Mohseni, Morvarid, Bentires-Alj, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256672/ https://www.ncbi.nlm.nih.gov/pubmed/37294349 http://dx.doi.org/10.1007/s10911-023-09539-9 |
Ejemplares similares
-
Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
por: Amante, Romain J., et al.
Publicado: (2022) -
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer
por: Vulin, Milica, et al.
Publicado: (2022) -
The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells
por: Zilli, Federica, et al.
Publicado: (2021) -
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization
por: Bogucka-Janczi, Katarzyna, et al.
Publicado: (2023) -
Cancer cell redirection biomarker discovery using a mutual information approach
por: Roche, Kimberly, et al.
Publicado: (2017)